Leonard Sachs
#62,076
Most Influential Person Now
Leonard Sachs's AcademicInfluence.com Rankings
Leonard Sachsbiology Degrees
Biology
#2118
World Rank
#3403
Historical Rank
Molecular Biology
#116
World Rank
#119
Historical Rank
Neuroscience
#166
World Rank
#175
Historical Rank
Biochemistry
#161
World Rank
#206
Historical Rank
Download Badge
Biology
Leonard Sachs's Degrees
- PhD Molecular Biology University of California, Berkeley
- Bachelors Biochemistry Stanford University
Why Is Leonard Sachs Influential?
(Suggest an Edit or Addition)Leonard Sachs's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 (1991) (2224)
- The cloning of normal "mast" cells in tissue culture. (1965) (823)
- Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia (1978) (582)
- Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. (1969) (459)
- Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. (1976) (453)
- In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. (1965) (426)
- Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. (1990) (362)
- In vitro control of the development of macrophage and granulocyte colonies. (1966) (350)
- The induction of clones of normal mast cells by a substance from conditioned medium. (1966) (334)
- Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. (1979) (328)
- Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. (1993) (319)
- Control of programmed cell death in normal and leukemic cells: new implications for therapy. (1993) (305)
- Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. (2001) (305)
- Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. (1993) (301)
- In Vitro Cell Transformation with Chemical Carcinogens (1963) (299)
- Structural Difference in Sites on the Surface Membrane of Normal and Transformed Cells (1969) (289)
- NQO1 stabilizes p53 through a distinct pathway (2002) (259)
- Cell‐mediated mutagenesis of mammalian cells with chemical carcinogens (1974) (243)
- In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. (1970) (242)
- Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. (1970) (232)
- Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 (2002) (228)
- The molecular control of blood cell development. (1987) (222)
- Lysosomal destabilization in p53-induced apoptosis (2002) (220)
- Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. (1992) (216)
- Different blocks in the differentiation of myeloid leukemic cells. (1974) (182)
- Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. (1980) (176)
- Rescue from programmed cell death in leukemic and normal myeloid cells. (1991) (173)
- THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPY (1978) (170)
- In Vitro Cell Transformation by X-Irradiation (1966) (170)
- FORMATION OF BONE TISSUE IN CULTURE FROM ISOLATED BONE CELLS (1974) (168)
- Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. (2005) (152)
- Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. (1973) (151)
- Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. (1996) (148)
- Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth (1973) (141)
- FORMATION OF PURE SUSPENSIONS OF MAST CELLS IN TISSUE CULTURE BY DIFFERENTIATION OF LYMPHOID CELLS FROM THE MOUSE THYMUS. (1963) (141)
- The control of hematopoiesis and leukemia: from basic biology to the clinic. (1996) (140)
- DNA rearrangement of a homeobox gene in myeloid leukaemic cells. (1988) (140)
- Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. (1969) (138)
- Differential Toxicity on Normal and Transformed Cells in vitro and Inhibition of Tumour Development in vivo by Concanavalin A (1970) (137)
- Control of lysozyme induction in the differentiation of myeloid leukemic cells (1976) (136)
- Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. (1972) (135)
- Feedback inhibition of the development of macrophage and granulocyte colonies. I. Inhibition by macrophage. (1967) (130)
- Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn‐superoxide dismutase: implications for Down syndrome. (1995) (129)
- Cytokine control of developmental programs in normal hematopoiesis and leukemia (2002) (128)
- Control of the Reversion of Properties in Transformed Cells (1970) (128)
- Regulation of megakaryocyte development by interleukin-6. (1989) (126)
- Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones (1975) (126)
- Chromosomal Control of Reversion in Transformed Cells (1971) (125)
- THE DIFFERENCE IN CONTACT INHIBITION OF CELL REPLICATION BETWEEN NORMAL CELLS AND CELLS TRANSFORMED BY DIFFERENT CARCINOGENS* (1966) (125)
- Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. (1968) (123)
- Cell differentiation and bypassing of genetic defects in the suppression of malignancy. (1987) (121)
- The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6 (1988) (121)
- Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. (1976) (119)
- Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene. (1966) (118)
- Reversion of Properties in Cells transformed by Polyoma Virus (1968) (117)
- Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. (1977) (114)
- The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. (1966) (113)
- Inhibition of lectin agglutinability by fixation of the cell surface membrane. (1973) (112)
- Membrane changes associated with malignancy. (1972) (111)
- Participation of myeloid leukaemic cells injected into embryos in haematopoietic differentiation in adult mice (1982) (107)
- In vivo inhibition of the development of myeloid leukemia by injection of macrophage‐and granulocyte‐inducing protein (1981) (107)
- Mutagenesis and transformation of normal cells by chemical carcinogens (1976) (106)
- Separation of different molecular forms of macrophage‐ and granulocyte‐inducing proteins for normal and leukemic myeloid cells (1980) (105)
- In Vitro Transformation of Normal Cells by Polyoma Virus (1961) (102)
- Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cells (1980) (101)
- Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. (1995) (100)
- Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. (1996) (99)
- In vivo induction of normal differentiation in myeloid leukemia cells. (1978) (97)
- Microviscosity in the surface membrane lipid layer of intact normal lymphocyte leukemic cells (1974) (96)
- Identification of the chromosomes that control malignancy. (1973) (94)
- The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. (1988) (94)
- Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells. (1973) (94)
- Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. (1996) (93)
- Growth, differentiation and the reversal of malignancy. (1986) (92)
- Induction of colony formation in vitro by human lymphocytes (1976) (92)
- Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture (1975) (91)
- Epigenetics and the plasticity of differentiation in normal and cancer stem cells (2006) (89)
- Chromosome mosaics in experimental amphiploids in the Triticinae (1952) (88)
- On the mechanism of polyoma virus-induced synthesis of cellular DNA. (1965) (88)
- Characterization of the inducer required for the development of macrophage and granulocyte colonies. (1971) (85)
- Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. (1999) (83)
- The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts (1991) (83)
- Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. (1967) (83)
- Metabolism of the carcinogenic hydrocarbon benzo(a)pyrene in human fibroblast and epithelial cells (1973) (83)
- Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. (1965) (82)
- A specific metabolic activity on the surface membrane in malignant cell-transformation. (1971) (80)
- Genetic dissection of the control of normal differentiation in myeloid leukemic cells. (1977) (79)
- The continued requirement for inducer for the development of macrophage and granulocyte colonies (1968) (78)
- Quantitation of N-acetyl-D-galactosamine-like sites on the surface membrane of normal and transformed mammalian cells. (1971) (76)
- The formation of variants with a reversion of properties of transformed cells. III. Reversion of the structure of the cell surface membrane (1969) (75)
- Indirect induction of differentiation in myeloid leukemic cells by lipid A. (1978) (75)
- Cell-to-cell binding induced by different lectins (1975) (75)
- Dna binding and its relationship to carcinogenesis by different polycyclic hydrocarbons (1977) (74)
- The control of growth and differentiation in normal and leukemic blood cells (1990) (74)
- Control of normal differentiation of myeloid leukemic cells. XI. Induction of a specific requirement for cell viability and growth during the differentiation of myeloid leukemic cells (1976) (72)
- p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1 (2003) (72)
- Characterization of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor. (1981) (72)
- The number of cell generations required to fix the transformed state in X-ray-induced transformation. (1968) (72)
- Epigenetics wins over genetics: induction of differentiation in tumor cells. (2002) (72)
- Temperature-sensitive activity on the surface membrane in the activation of lymphocytes by lectins. (1973) (71)
- QUANTITATION OF A MURINE LEUKEMIA VIRUS WITH A SPLEEN COLONY ASSAY. (1964) (71)
- Mutation induction in chinese hamster V79 cells by two vinyl chloride metabolites, chloroethylene oxide and 2‐chloroacetaldehyde (1975) (71)
- Complete preimplantation development in culture of parthenogenetic mouse embryos. (1976) (70)
- Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. (1982) (69)
- Hybridization between SV40 DNA and cellular DNA's. (1969) (67)
- Control of normal differentiation of myeloid leukemic cells. IV. Induction of differentiation by serum from endotoxin treated mice (1974) (67)
- Cell-virus interactions with the polyoma virus. 1. Studies on the lytic interaction in the mouse embryo system. (1960) (67)
- Surface membrane glycopeptides correlated with tumorigenesis. (1973) (67)
- The activation of virus synthesis in polyoma-transformed cells. (1969) (64)
- Polyploid evolution and mammalian chromosomes (1952) (64)
- Difference in the mobility of lectin sites on the surface membrane of normal lymphocytes and malignant lymphoma cells (1973) (64)
- Molecular dissection of differentiation in normal and leukemic myeloblasts: separately programmed pathways of gene expression. (1980) (63)
- The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. (1968) (63)
- Developmental potential of myeloid leukemia cells injected into midgestation embryos. (1984) (62)
- Control of normal differentiation of myeloid leukemic cells. XII. Isolation of normal myeloid colony‐forming cells from bone marrow and the sequence of differentiation to mature granulocytes in normal and D+ myeloid leukemic cells (1977) (62)
- Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. (1994) (62)
- Induction of virus synthesis in polyoma transformed cells by ultraviolet light and mitomycin C. (1970) (61)
- Control of growth and normal differentiation in leukemic cells: Regulation of the developmental program and restoration of the normal phenotype in myeloid leukemia (1982) (60)
- Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A. (1974) (60)
- In vitro induction of myeloid proliferation and maturation in infantile genetic agranulocytosis. (1971) (59)
- Chromosome behaviour in species hybrids with Triticum timopheevi (1953) (59)
- A plaque assay for the polyoma virus. (1959) (59)
- Distribution of surface charge and concanavalin A-binding sites on normal and malignant transformed cells. (1974) (59)
- Control of in vivo differentiation of myeloid leukemic cells. iv. inhibition of leukemia development by myeloid differentiation‐inducing protein (1984) (58)
- Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles (2007) (58)
- In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3. (1988) (57)
- Coupling of growth and differentiation in normal myeloid precursors and the breakdown of this coupling in leukemia (1983) (56)
- Transplantability of an x-ray-induced and a virus-induced leukemia in isologous mice inoculated with a leukemia virus. (1962) (56)
- Blocks in ganglioside synthesis in transformed hamster cells and their revertants. (1974) (55)
- Purification of the protein that induces cell differentiation to macrophages and granulocytes (1973) (54)
- Regulation of actin and other proteins in the differentiation of myeloid leukemic cells (1978) (54)
- Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells. (1990) (54)
- Haematopoietic growth factors (1984) (53)
- Chromosome balance and the control of malignancy (1976) (53)
- Requirement for cell replication after SV40 infection for a structural change of the cell surface membrane. (1970) (52)
- Receptor mobility and the binding of cells to lectin-coated fibers (1975) (52)
- Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. (1998) (51)
- Differences in the binding of fluorescent concanavalin A to the surface membrane of normal and transformed cells. (1972) (51)
- The formation of variants with a reversion of properties of transformed cells. I. Variants from polyoma-transformed cells grown in vivo. (1969) (50)
- The development and suppression of polyploidy in the developing and suppressed deciduoma in the rat. (1955) (50)
- Normal granulocyte colony-forming cells in the bone marrow of Yemenite Jews with genetic neutropenia. (1973) (49)
- Sex-linkage and the sex chromosomes in man. (1952) (49)
- The Mechanism of Carcinogenesis (1972) (49)
- Surface Membrane Glycopeptides Which Coincide with Virus Transformation and Tumorigenesis (1974) (49)
- Enzyme regulation in neuroblastoma cells. Selection of clones with low acetylcholinesterase activity and the independent control of acetylcholinesterase and choline-O-acetyltransferase. (1972) (48)
- Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia. (1984) (48)
- Different cyclic changes in the surface membrane of normal and malignant transformed cells. (1974) (48)
- Temperature sensitivity of polyoma virus, induction of cellular DNA synthesis, and multiplication of transformed cells at high temperature. (1967) (48)
- Differences in Inducing Activity for Human Bone Marrow Colonies in Normal Serum and Serum From Patients With Leukemia (1973) (47)
- A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. (1995) (46)
- Control of hematopoietic cell growth regulators during mouse fetal development (1987) (46)
- Sex chromosomes and human sexual development. (1957) (45)
- Lectin receptors on the cell surface membrane and the kinetics of lectin-induced cell agglutination. (1975) (45)
- Chromosomal control of malignancy in tumors from cells transformed by polyoma virus (1973) (45)
- Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene. (1992) (45)
- Regulation of acetylcholine receptors in relation to acetylcholinesterase in neuroblastoma cells. (1973) (44)
- Regulation of gene expression by tumor promoters. II. Control of cell shape and developmental programs for macrophages and granulocytes in human myeloid leukemic cells (1981) (44)
- Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex. (1990) (43)
- The diagnosis of sex before birth using cells from the amniotic fluid (a preliminary report). (1955) (43)
- Identification of a chromosome that controls malignancy in chinese hamster cells (1977) (42)
- Difference in the cellular cholesterol to phospholipid ratio in normal lymphocytes and lymphocytic leukaemic cells (1974) (41)
- Regulation of aryl hydrocarbon (benzo-(A)-pyrene) hydroxylase activity in mammalian cells. Induction of hydroxylase activity by N6,O2'-dibutyryl8 adenosine 3':5'-monophosphate and aminophylline. (1975) (41)
- A Theory on the Mechanism of Carcinogenesis by Small Deoxyribonucleic Acid Tumour Viruses (1965) (40)
- Regulation of cell surface receptors for different hematopoietic growth factors on myeloid leukemic cells. (1986) (40)
- Temperature sensitivity of cyclic adenosine 3':5'-monophosphate-binding proteins and the regulation of growth and differentiation in neuroblastoma cells. (1975) (40)
- Transformation of normal hamster cells by benzo(a)pyrene diol‐epoxide (1977) (39)
- Cell transformation by polyoma virus in clones of hamster and mouse cells. (1962) (39)
- Cytokines as suppressors of apoptosis (1999) (39)
- The Wellcome Foundation Lecture, 1986 - The molecular regulators of normal and leukaemic blood cells (1987) (39)
- Properties of a Somatic Hybrid between Mouse Cells with Different Genotypes (1963) (39)
- Prenatal diagnosis of sex using cells from the amniotic fluid. (1956) (39)
- The formation of variants with a reversion of properties of transformed cells. V. Reversion to a limited life‐span (1970) (39)
- Regulation of the induction of colonies in vitro by normal human lymphocytes. (1976) (38)
- Regulation and role of different macrophage‐ and granulocyte‐inducing proteins in normal and leukemic myeloid cells (1982) (38)
- THE INDUCTION OF FORSSMAN-ANTIGEN SYNTHESIS IN HAMSTER AND MOUSE CELLS IN TISSUE CULTURE, AS DETECTED BY THE FLUORESCENT-ANTIBODY TECHNIQUE. (1964) (38)
- Control of Fc and C3 receptors on myeloid leukemic cells. (1976) (38)
- The in vitro formation of a stable cell-virus association with polyoma virus☆ (1960) (37)
- Isolectins from wax bean with differential agglutination of normal and transformed mammalian cells. (1973) (37)
- Changes in the surface membrane of lymphocytes from patients with chronic lymphocytic leukemia and hodgkin's disease (1975) (36)
- Deletion of a homeobox gene in myeloid leukemias with a deletion in chromosome 2. (1988) (36)
- The chromosomes and transplantability of tumors. I. Fundamental chromosome numbers and strain specificity in ascites tumors. (1955) (35)
- Control of normal differentiation of myeloid leukemic cells. VI. Inhibition of cell multiplication and the formation of macrophages (1975) (35)
- Alkaline phosphatase activity and the regulation of growth in transformed mammalian cells (1974) (34)
- Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. (1997) (34)
- Studies on the lytic interaction and cell transformation with a large- and a small-plaque mutant of polyoma virus (1963) (34)
- Chromosomal control of chemical carcinogenesis (1972) (34)
- Genetic dissociation of different cellular effects of interferon on myeloid leukemic cells (1978) (34)
- Characteristics of a Ca2+/calmodulin-dependent binding of the Ca2+ channel antagonist, nitrendipine, to a postsynaptic density fraction isolated from canine cerebral cortex. (1986) (34)
- Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells. (1989) (34)
- Steroid hormone receptors and the differentiation of myeloid leukemic cells (1977) (34)
- In Vitro Analysis of a Mammalian Tumour Virus (1959) (33)
- The formation of variants with a reversion of properties of transformed cells. II. In vitro formation of variants from polyoma-transformed cells. (1969) (33)
- Membrane changes and adenosine triphosphate content in normal and malignant transformed cells. (1973) (33)
- Cell-virus Interactions with the Polyoma Virus: The Induction of Cell Transformation and Malignancy in vitro (1961) (33)
- Enzymatic hydrolysis of uridine diphosphate-N-acetyl-D-galactosamine and uridine diphosphate-N-acetyl-D-glucosamine by normal cells, and blocks in this hydrolysis in transformed cells and their revertants. (1972) (33)
- The Molecular Regulators of Macrophage and Granulocyte Development (1989) (33)
- Rotational diffusion of lectins bound to the surface membrane of normal lymphocytes (1973) (33)
- Feedback inhibition of the development of macrophage and granulocyte colonies. II. Inhibition by granulocytes. (1969) (33)
- Mobility of concanavalina receptors on the surface membrane of lymphocytes from normal persons and patients with chronic lymphocytic leukemia (1974) (32)
- The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen. (1970) (32)
- Clonal regulation of the induction of macrophageand granulocyte‐inducing proteins for normal and leukemic myeloid cells (1980) (32)
- Inhibition of ascites tumor development by concanavalin a (2006) (31)
- Co-regulation of type C RNA virus production and cell differentiation in myeloid leukemic cells (1978) (31)
- Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease. (1975) (31)
- Investigations in the Triticinae II. The cytology and fertility of intergeneric and interspecific F1 hybrids and their derived amphidiploids (1953) (31)
- Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells (1989) (31)
- Constitutive gene expression in myeloid leukemia and cell competence for induction of differentiation by the steroid dexamethasone. (1981) (31)
- Cell-virus interactions with the polyoma virus. II. Studies on the nature of the interaction in tumor cells. (1961) (31)
- Control of normal differentiation of myeloid leukemic cells. V. Normal differentiation in aneuploid leukemic cells and the chromosome banding pattern of D+ and D− clones (1974) (30)
- Inhibition of differentiation and affinity purification with a monoclonal antibody to a myeloid cell differentiation-inducing protein. (1988) (30)
- Tumor transplantation in mice inoculated with polyoma virus. (1961) (30)
- Polyoma virus synthesis in tumor cells as measured by the fluorescent antibody technique. (1960) (30)
- The giant sex chromosomes in the mammal Microtus agrestis (1953) (29)
- The Network of Hematopoietic Cytokines (1994) (29)
- The early development of haploid and aneuploid parthenogenetic embryos. (1975) (28)
- In vitro culture of a mammalian leukemia virus. (1961) (28)
- Genetic control of the regulation of cell susceptibility to carcinogenic polycyclic hydrocarbons by cyclic AMP (1974) (28)
- Role of different normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells (1988) (28)
- Polyoma Virus Mutant with a Reduction in Tumour Formation (1960) (27)
- Indirect induction of differentiation of normal and leukemic myeloid cells by recombinant interleukin 1. (1989) (26)
- Production of the inducer for macrophage and granulocyte colonies by leukemic cells (1968) (26)
- Differential desensitization of functional adrenergic receptors in normal and malignant myeloid cells: relationship to receptor-mediated hormone cytotoxicity. (1978) (26)
- The mechanism of leukemogenesis by the Rauscher leukemia virus. (1966) (26)
- Temperature-sensitive agglutinability of human erythrocytes by lectins. (1972) (26)
- Tumor induction by genetically homogeneous lines of polyoma virus. (1961) (26)
- Long-term cultivation in tissue culture of leukemic cells from mouse leukemia induced by Moloney virus or by x rays. (1961) (25)
- Histone distribution in chromosomes revealed by antihistone sera. (1976) (25)
- Protection of human myeloid leukemic cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin 3. (1996) (25)
- Mobility of carbohydrate-containing structures on the surface membrane and the normal differentiation of myeloid leukemic cells to macrophages and granulocytes. (1973) (25)
- Independent regulation of two types of aryl hydrocarbon (benzo(a)pyrene) hydroxylase in mammalian cells (1976) (25)
- Activation of a differentiation-inducing protein by adenine and adenine containing nucleotides. (1971) (25)
- Studies on the antigenic composition of hamster tumors induced by polyoma virus, and of normal hamster tissues in vivo and in vitro. (1962) (25)
- Control mechanisms regulating gene expression during normal differentiation of myeloid leukemic cells: differentiation defective mutants blocked in mRNA production and mRNA translation. (1981) (25)
- Regulation of gene expression by tumor promoters. III. Complementation of the developmental program in myeloid leukemic cells by regulating mRNA production and mRNA translation (1981) (24)
- p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. (2004) (24)
- The molecular control of hematopoiesis: from clonal development in culture to therapy in the clinic. (1992) (24)
- Desensitization of enucleated cells to hormones and role of cytoskeleton in control of normal hormonal response. (1980) (24)
- Different locations of carbohydrate-containing sites in the surface membrane of normal and transformed mammalian cells (1970) (24)
- Specific aggregation of SV40-transformed cells by ornithine, leucine copolymers. (1970) (24)
- Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells. (1995) (24)
- Autoinduction of differentiation in myeloid leukemic cells: restoration of normal coupling between growth and differentiation in leukemic cells that constitutively produce their own growth‐inducing protein. (1982) (23)
- THE TEMPORAL RELATIONSHIPS OF PROTEIN AND DNA SYNTHESIS IN POLYOMA VIRUS DEVELOPMENT. (1964) (23)
- DNA‐binding protein that induces cell differentiation. (1983) (23)
- Integration of viral into chromosomal deoxyribonucleic acid in an inducible line of polyoma-transformed cells. (1973) (23)
- Formation of Different Cell–Virus Relationships in Tumour Cells Induced by Polyoma (1959) (23)
- The chromosomes and transplantability of tumors. II. Chromosome duplication and the loss of strain specificity in solid tumors. (1956) (22)
- Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes (2003) (22)
- Simple methods for mammalian chromosomes. (1953) (22)
- The formation of variants with a reversion of properties of transformed cells. vi. stability of the reverted state (1972) (22)
- Sub-Diploid Chromosome Variation in Man and other Mammals (1953) (22)
- Regulation of cap formation by concanavalin A and differentiation of myeloid leukemic cells. Relationship to free and anchored surface receptors. (1976) (21)
- Difference in the calcium regulation of concanavalin A agglutinability and surface microvilli in normal and transformed cells. Relationship to membrane--cytoskeleton interaction. (1977) (21)
- An analysis of the mechanism of neoplastic cell transformation by polyoma virus, hydrocarbons, and x-irradiation. (1967) (21)
- The sex-linked histocompatibility antigens. (1958) (21)
- Constitutive uncoupling of the controls for growth and differentiation in myeloid leukemia and the development of cancer. (1980) (21)
- The single cell origin of normal granulocyte colonies in vitro (1969) (21)
- Modulation of cell competence for induction of differentiation in myeloid leukemic cells (1982) (21)
- Virus Deoxyribonucleic Acid Sequences in Subdiploid and Subtetraploid Revertants of Polyoma- Transformed Cells (1972) (21)
- Control of normal differentiation of myeloid leukemic cells. XII. Inducibility for some stages of differentiation by dimethylsulfoxide and its disassociation from inducibility by MGI (1978) (20)
- The molecular control of hemopoiesis and leukemia. (1993) (20)
- The network of hemopoietic regulatory proteins in myeloid cell differentiation. (1991) (20)
- Control of in vivo differentiation of myeloid leukemic cells. III. Regulation By T Lymphocytes And Inflammation (1983) (20)
- A deletion and a rearrangement distinguish between the intracisternal A-particle of Hox-2.4 and that of interleukin-3 in the same leukemic cells. (1991) (20)
- Differences in surface membrane ecto‐ATPase and ecto‐AMPase in normal and malignant cells I. Decrease in ecto‐ATPase in myeloid leukemic cells and the independent regulation of ecto‐ATPase and ecto‐AMPase (1977) (20)
- Human cancers overexpress genes that are specific to a variety of normal human tissues. (2005) (20)
- The chromosome constancy of the normal mammalian uterus (1954) (20)
- Control of in vivo differentiation of myeloid leukemic cells. (1988) (19)
- Enhancement of hormone action by a phorbol ester and anti-tubulin alkaloids involves different mechanisms. (1982) (19)
- Control of normal differentiation of myeloid leukemic cells. X. Glucose utilization, cellular ATP and associated membrane changes in D+ and D− cells (1976) (19)
- The adventures of a biologist: prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis, and tumor suppression. (1995) (19)
- Existence of a Ca2+-dependent K+ channel in synaptic membrane and postsynaptic density fractions isolated from canine cerebral cortex and cerebellum, as determined by apamin binding (1985) (19)
- Induction of genes for transcription factors by normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells. (1990) (19)
- Type C RNA virus production and cell competence for normal differentiation in myeloid leukaemic cells (1977) (19)
- Clonal variation in susceptibility to differentiation by different protein inducers in the myeloid leukemia cell line M1. (1989) (19)
- The In Vitro and In Vivo Analysis of Mammalian Tumour Viruses (1959) (18)
- The In Vitro and In Vivo Analysis of Mammalian Tumour Viruses (1959) (18)
- Chromosomal mechanism for the induction of reversion in transformed cells (1972) (18)
- Activation of simian virus 40 by transfer of isolated chromosomes from transformed cells. (1974) (18)
- Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells. (1989) (18)
- Review of clinical and haematological response to low‐dose cytosine arabinoside in acute myeloid leukaemia (1987) (18)
- INDUCTION AND REPRESSION OF ANTIGENIC MATERIAL (FORSSMAN TYPE) IN RELATION TO CELL ORGANIZATION. (1964) (17)
- SEX‐LINKAGE and THE SEX CHROMOSOMES IN MAN ADDENDUM (1954) (17)
- The cloning of macrophages in agar: Identification of the cells by electron microscopy (1966) (17)
- Independent regulation of myeloid cell growth and differentiation inducing proteins: In vivo regulation by compounds that induce inflammation (1985) (17)
- The antibody response to successful tumor homografts. (1957) (17)
- Induction of polyadenylate polymerase and differentiation in neuroblastoma cells. (1975) (17)
- Restriction of receptor mobility and the agglutination of cells by concanavalin A. (1975) (17)
- Genetic control of haploid parthenogenetic development in mammalian embryos (1975) (17)
- Immunogenetic properties of tumors that have acquired homotransplantability. (1958) (16)
- Increase of normal myeloblast viability and multiplication without blocking differentiation by type C RNA virus from myeloid leukemic cells. (1979) (16)
- Cytoskeleton regulates β‐adrenergic hormonal stimulation in normal and leukemic white blood cells (1978) (16)
- Regulation of cell‐surface receptors for hematopoietic differentiation‐inducing protein MGI‐2 on normal and leukemic myeloid cells (1987) (16)
- In vivo control of differentiation of myeloid leukemic cells by cyclosporine A and recombinant interleukin-1 alpha. (1988) (16)
- Analysis of Amniotic Fluid Cells for Diagnosis of Foetal Sex (1956) (16)
- Control of in-vivo differentiation of myeloid leukemic cells--V. Regulation by response to antigen. (1985) (16)
- Activation of normal genes in malignant cells: Activation of chemotaxis in relation to other stages of normal differentiation in myeloid leukemia (1979) (16)
- Screening for induction of differentiation and toxicity to blast cells by chemotherapeutic compounds in human myeloid leukemia. (1985) (16)
- The occurrence of hybrid semi-lethals and the cytology of Triticum macha and Triticum vavilovi (1953) (16)
- The possibilities of crossing-over between the sex chromosomes of the house mouse (2005) (16)
- Availability of L-fucose-like sites on the surface membrane of normal and transformed mammalian cells. (1972) (15)
- Control of cloning of normal human T lymphocytes by transferrin, albumin and different lectins. (1978) (15)
- CELL-VIRUS INTERACTIONS WITH THE SHOPE FIBROMA VIRUS ON CULTURES OF RABBIT AND RAT CELLS. (1964) (15)
- Protein that induces cell differentiation causes nicks in double‐stranded DNA (1986) (15)
- The stimulation of tumor cell growth by a substance produced by normal and tumor cells (1969) (15)
- Synchrony of gene expression and the differentiation of myeloid leukemic cells: reversion from constitutive to inducible protein synthesis. (1983) (14)
- Reversible inhibition of cAMP-induced axon formation in neuroblastoma cells by concanavalin A and vinblastine. Relationship to microtubules and cytotoxicity. (1975) (14)
- Different mechanisms for the induction of acetylcholinesterase in neuroblastoma cells. (1975) (14)
- Conversion of met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A) (1981) (13)
- Regulation of human T cell colonies by an inducing activity (TCI) produced by normal human and malignant mouse cells. (1978) (13)
- A highly specific aminotripeptidase of rat brain cytosol. Substrate specificity and effects of inhibitors. (1982) (13)
- INHIBITION OF INTERFERON PRODUCTION IN HAMSTER CELLS TRANSFORMED IN VITRO WITH CARCINOGENIC HYDROCARBONS. (1964) (13)
- Suppression of the in vivo malignancy and in vitro cell multiplication of myeloid leukemic cells by hybridization with normal macrophages. (1978) (13)
- Susceptibility of cells transformed by polyoma virus and simian virus 40 to the cytotoxic effect of the carcinogenic hydrocarbon benzo[a]pyrene. (1968) (13)
- Metabolism of the carcinogenic hydrocarbon benzo(a)pyrene in human fibroblast and epithelial cells. II. Differences in metabolism to water‐soluble products and aryl hydrocarbon hydroxylase activity (1977) (13)
- Target‐cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: Two regulators secreted by krebs carcinoma cells (1988) (13)
- Leukemia induction in mice by Moloney virus from long- and short-term tissue cultures, and attempts to detect a leukemogenic virus in cultures from x-ray-induced leukemia. (1962) (13)
- Blocks in nucleotide phosphodiesterase and alkaline phosphatase activity in transformed mammalian cells (1973) (12)
- The diagnosis of the sex chromosomes in human tissues (1957) (12)
- Cytotoxic antibodies in the homograft reaction. (1958) (12)
- Regulation of endogenous type C virus expression during normal myeloid cell differentiation. Evidence for a role in promoting myeloid cell proliferation and differentiation. (1980) (12)
- Difference in the cell proliferation and colony-forming ability of normal human T lymphocytes. (1979) (12)
- Temperature sensitivity of cyclic-adenosine-3':5'-monophosphate-binding proteins, activity of protein kinases and the regulation of cell growth. (1975) (11)
- The in vitro and in vivo analysis of mammalian tumor viruses. IV. Antibody response and tumor induction with polyoma virus in different species. (1960) (11)
- An Analysis of the Mechanism of Carcinogenesis by Polyoma Virus, Hydrocarbons, and X-Irradiation (1966) (11)
- Cell differentiation and tumour suppression. (1989) (11)
- Constitutive gene expression and restoration of the normal phenotype in malignant cells: a model for the origin and evolution of leukemia. (1981) (11)
- The chromosomes and transplantability of tumors. III. The transplantability of mouse tumors with different degrees of strain specificity into previously immunized mice. (1956) (11)
- Challenge infection of polyoma parotid tumor cells. (1962) (10)
- 45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells (1992) (10)
- Hematopoietic growth and differentiation factors and the reversibility of malignancy: Cell differentiation and by-passing of genetic defects in leukemia (1986) (10)
- The proteins that control haemopoiesis and leukaemia. (1990) (10)
- Multimeric complexes of differentiation-inducing protein bound to DNA. (1985) (10)
- Cell differentiation and malignancy (1986) (10)
- Membrane Differences in Peripheral Blood Lymphocytes from Patients with Chronic Lymphocytic Leukemia and Hodgkin's Disease (1975) (10)
- Mobility of Concanavalin A receptors on the surface membrane of lymphocytes from normal persons and patients with chronic lymphocytic leukemia. (1974) (10)
- PRENATAL IDENTIFICATION OF BLOOD-GROUP ANTIGENS (1956) (9)
- Induction in myeloid leukemic cells of genes that are expressed in different normal tissues. (2004) (9)
- The in vitro and in vivo analysis of mamalian tumour viruses: experiments on the epidemiology of the polyoma virus. (1959) (9)
- Regulators of growth, differentiation, and the reversion of malignancy: normal hematopoiesis and leukemia (1985) (9)
- Regulation of in-vivo differentiation of myeloid leukemic cells by antigen-specific helper T lymphocytes. (1986) (9)
- Translation of polysomal messenger RNA during epidermal differentiation. (1975) (9)
- Separation of epidermal layers of the newborn rat. (1977) (9)
- Cytokine and apoptosis gene networks that control development and cancer (1997) (8)
- Nuclear control of neurite induction in neuroblastoma cells. (1978) (8)
- Selective regulation by hydrocortisone of induction of in vivo differentiation of myeloid leukemic cells with granulocyte-macrophage colony-stimulating factor, interleukin 6 and interleukin 1 alpha. (1992) (8)
- Control of normal cell differentiation in leukemia. (1977) (8)
- A cause of variation in clonal morphology of polyoma transformed hamster cells. (1965) (8)
- The cellular and molecular environment in leukemia. (1993) (8)
- Induction of normal cell differentiation in leukemia as an approach to cancer therapy. (1983) (8)
- Changes in the structural organization of the surface membrane in malignant cell transformation (1971) (8)
- Leukemogenesis and differentiation. (1985) (7)
- Gene activation by transfer of isolated mammalian chromosomes. II. Activation of simian virus 40 by transfer of fractionated chromosomes from transformed cells. (1976) (7)
- Location of amino acid and carbohydrate transport sites in the surface membrane of normal and transformed mammalian cells (1971) (7)
- Production of human T cell colony-inducing activity (TCI) by malignant cells from patients with lymphocytic and myeloid leukemia. (1979) (7)
- Differences in inducing activity for human bone marrow colonies in normal serum and serum from patients with leukemia. (1973) (7)
- Cell competence for industion of differentiation by insulin and other compounds in myeloid leukemic clones continuously cultured in serum-free medium. (1982) (7)
- RESISTANCE AND SUSCEPTIBILITY TO CHALLENGE INFECTION OF POLYOMA- INDUCED TUMOR CELL CLONES. (1963) (6)
- METABOLISM OF ENKEPHALIN ANALOGUES AND SURROGATES HAVING ENHANCED PHARMACOLOGIC ACTIVITIES * (1982) (6)
- The formation of variants with a reversion of properties of transformed cells. VII. Chromosome numbers and re‐reversion in subtetraploid variants (1972) (6)
- The formation of variants with a reversion of properties of transformed cells. VIII. in vitro limited life span of variants isolated from tumors (1972) (6)
- The temperature sensitivity of a small-plaque mutant of polyoma virus. (1965) (6)
- The Molecular Control of Normal and Leukemic Hematopoiesis: Myeloid Cells as a Model System a (1989) (6)
- Opening remarks/keynote address (1991) (6)
- Regulation of leukaemic cells by interleukin 6 and leukaemia inhibitory factor. (1992) (5)
- The early synthesis of RNA in polyoma virus development. (1966) (5)
- Hematopoietic Growth and Differentiation Factors and the Reversal of Malignancy (1987) (5)
- Control of normal cell differentiation in leukemic cells. (1976) (5)
- CHROMOSOME NUMBERS AND EXPERIMENTAL POLYPLOIDY IN THE PIG (1954) (5)
- Surface membrane changes in lymphocytes from patients with infectious mononucleosis (1977) (5)
- Angiogenesis--cytokines as part of a network. (1992) (5)
- ANTENATAL IDENTIFICATION OF HEREDITARY DISORDERS (1956) (5)
- Molecular control of development in normal and leukemic myeloid cells by cytokines, tumor suppressor and oncogenes. (1996) (5)
- Chromosomal and growth factor abnormalities in leukemia. AACR special conference in cancer research. (1991) (5)
- Role of phospholipase A2 and prostaglandin E in growth and differentiation of myeloid leukemic cells. (1982) (5)
- Activation of normal differentiation genes and the origin and development of myeloid leukemia. (1980) (4)
- Possibility of Prenatal Diagnosis of Sex in Cattle and Sheep (1956) (4)
- The molecular control of haemopoiesis and leukaemia (1994) (4)
- The Molecular Control of Hematopoiesis and Leukemia: From Basic Biology to the Clinic. (2000) (4)
- The in vitro analysis of malignancy induced by polyoma virus. (1963) (4)
- Regulation of growth and differentiation by phorbol esters and the mechanism of tumor promotion. (1982) (4)
- Studies on the role of viruses in the origin of mammalian tumors. (1961) (4)
- Regulatory proteins for growth and differentiation in normal and leukemic hematopoietic cells: normal differentiation and the uncoupling of controls in myeloid leukemia. (1984) (4)
- Feedback control of the development of hematopoietic cell clones in vitro, and the mechanism of leukemogenesis. (1969) (3)
- Regulators of normal development and tumor suppression. (1993) (3)
- Constitutive gene expression and the uncoupling of controls in leukemia regulatory proteins that control growth and differentiation in normal and leukemic myeloid cells (1983) (3)
- Constitutive uncoupling of the controls for growth and differentiation in myeloid leukemia a general model for the origin and development of malignancy (1980) (3)
- 6 – THE GENETIC IMPLICATIONS OF NUCLEAR SEXING (1958) (3)
- Mapping of sites on the surface membrane of mammalian cells (1972) (3)
- Some systems for the genetic analysis of mammalian cells. (1960) (3)
- Virus Release from Single Cells of Mouse Parotid Tumours (1960) (3)
- Cell susceptibility to the cytotoxic effect of the carcinogens dimethylnitrosamine and N-nitrosomethylurea. (1970) (2)
- Interaction of the basic copolymer — poly(ornithine, leucine) with normal and transformed cells (1975) (2)
- The In Vitro and In Vivo Analysis of Mammalian Tumour Viruses (1959) (2)
- Differences in the formation of normal T lymphocyte colonies by peripheral blood cells from patients with chronic lymphocytic leukemia and Hodgkin's disease. (1979) (2)
- Control of endogenous cell regulators by the second‐stage tumor promoter phorbol‐12‐retinoate 13‐acetate (1983) (2)
- Diagnostic and therapeutic implications of cell cultures for human leukemias. (1979) (2)
- Regulators of Growth, Differentiation and the Reversal of Malignancy (1985) (2)
- The molecular regulators of normal and leukemic hematopoietic cells. (1988) (2)
- Opening remarks. A visionary assessment of the scientific, clinical, and economic implications of hematopoietic growth factors. (1991) (1)
- Regulation of growth and differentiation in normal haematopoietic and leukaemic cells. (1973) (1)
- THE SEX CHROMOSOMES IN HUMAN INTERSEXES (1956) (1)
- Correction for Bock-Axelsen et al., Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles (2007) (1)
- Cytoskeleton regulates beta-adrenergic hormonal stimulation in normal and leukemic white blood cells. (1978) (1)
- The control of growth and differentiation in normal and leukemic blood cells (1)
- Origin and reversibility of malignancy. (1985) (1)
- Control of cell differentiation in normal hematopoietic and leukemic cells. (1977) (1)
- Characterization oftheInducer Required fortheDevelopment ofMacrophage andGranulocyte Colonies (hematopoietic/cofactor/cyclic AMP/ultrafiltration/protein inducer) (1971) (1)
- Cell Differentiation and Malignancy in Leukemia (1979) (1)
- The diagnosis of fetal sex during pregnancy. (1957) (1)
- THE PRENATAL DIAGNOSIS OF HUMAN ABNORMALITIES (1956) (1)
- Normal regulators of growth and differentiation and the reversal of malignancy in leukemia. (1985) (1)
- Cancer Research: A Molecular Approach to Therapy (1972) (1)
- [Chromosomal basis of malignancy]. (1971) (1)
- CONTROL OF GROWTH AND DIFFERENTIATION IN NORMAL AND MALIGNANT LEUKOCYTES: THE PROTEIN REGULATORS MGI AND TCI (1979) (0)
- granulocyte-macrophage colony-stimulating factor and interleukin 3 In vivo control of differentiation of myeloid leukemic cells by recombinant (2011) (0)
- Stem cell biology: Molecular control of normal hematopoiesis, leukemia and apoptosis (2001) (0)
- resistant to induction of apoptosis by some agents Hematopoietic cells from mice deficient in wild-type p53 are more (2011) (0)
- Proceedings: Cellular ATP, membrane dynamics and the agglutination of cells by concanavalin A. (1975) (0)
- Difference in the mobility of carbohydrate containing structures on the surface membrane of normal and malignant transformed cells. (1974) (0)
- [Apoptosis--programmed cell death--molecular aspect]. (1995) (0)
- Activation of normal differentiation and restoration of the normal phenotype in leukemia. (1982) (0)
- Proceedings: Activation of SV40 by transfer of fractionated chromosomes from transformed cells. (1975) (0)
- Synchrony of Gene Expression and Regulation of the Developmental Program in Normal and Leukemic Cells (1982) (0)
- Biology and oncology: regulation of growth, differentiation and malignancy. (1983) (0)
- Control ofNormalDifferentiation ofMyeloid Leukemic Cells toMacrophages andGranulocytes (mice/chromosome number/differentiation-inducing protein) (1973) (0)
- [Differences in structure and location of binding sites on cell surface membranes of normal and transformed cells]. (1971) (0)
- Control of normal cell differentiation in leukemic cells. (1976) (0)
- The immunogenetic properties of tumor cells. (1960) (0)
- FURTHER EVIDENCE CONCERNING CHROMOSOME NUMBERS IN THE PIG (1954) (0)
- Autoregulation ofInterleukin 6andGranulocyte-Macrophage Colony-Stimulating Factor intheDifferentiation of Myeloid Leukemic Cells (1989) (0)
- MICROTUBULES REGULATE CATECHOLAMINE AND PROSTAGLANDIN E1 FUNCTION (1979) (0)
- Different Blocks intheDifferentiation ofMyeloid LeukemicCells (surface receptors forerythrocytes sensitized withantibody andwithantibody andcomplement/rosettes withsensitized erythrocytes/macrophages/granulocytes) (1974) (0)
- Cancer genetics and cancer suppression. (1990) (0)
- Regulation of p53 stability ai apoptosis by NADH quinone ( (2016) (0)
- Conversion of Met-enkephalin-Arg-Phe by brain carboxypeptidases and by membrane fractions. (1982) (0)
- Constitutive Uncoupling of Pathways of Gene Expression that Control Growth and Differentiation and the Molecular Mechanism of Carcinogenesis (1980) (0)
- Regulation of Growth and Differentiation in Normal and Leukemic Hematopoiesis (1989) (0)
- Growth factors in cancer therapy: The control of hematopoiesis as a model system (1993) (0)
- Perspectivesin CancerResearch Cell Differentiation and Bypassing of Genetic Defects in the Suppression of Malignancy1 (2006) (0)
- The molecular control of development in normal and leukemic blood cells. (1996) (0)
- 290. The origin and reversibility of malignancy (1987) (0)
- Table of Contents (1983) (0)
- Molecular biology of haematopoiesis : proceedings of the International Symposium on Molecular Biology of Haematopoiesis, Innsbruck, Austria, 9-12 July 1989 (1990) (0)
- MembraneDifferences inPeripheral BloodLymphocytes fromPatients withChronic Lymphocytic LeukemiaandHodgkin's Disease (concanavalin A/cell agglutination/cell attaclhment/cap formation) (1975) (0)
- [Structural differences on the surface membrane of normal and malignant transformed cells as a tool in tumor therapy]. (1971) (0)
- [Growth and differentiation of hematopoietic cells in vitro]. (1973) (0)
- Mobility ofCarbohydrate-Containing Structures ontheSurface Membraneandthe NormalDifferentiation ofMyeloid Leukemic Cells toMacrophages andGranulocytes (1973) (0)
- The Cytokines that Control Haemopoiesis and their Use in the Clinic (1993) (0)
- Normal differentiation and genetic changes in cancer cells. (1982) (0)
- Cell Differentiation and Programmed Cell Death: A New Approach to Leukemia Therapy (1996) (0)
- The control of hematopoiesis : from cell cultures to therapy (1993) (0)
- interleukin-6 The myeloid blood cell differentiation-inducing protein MGI-2A is (2011) (0)
- leukemic cells myeloid growth factor beta 1 and cancer chemotherapy compounds in Hematopoietic cytokines inhibit apoptosis induced by transforming (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Leonard Sachs?
Leonard Sachs is affiliated with the following schools:
